Fostering Innovative Technologies, Sustainable Solutions, and Social Development

Scindy Pharmaceutical is an R&D enterprise that excels in the nanocarrier field, with a focus on independent innovations. Our R&D activities, guided by the precision of molecular simulations and the reliability of empirical data, have led to the development of a pioneering LNP platform, i-Core. This platform addresses the complex challenges associated with siRNA and mRNA delivery, both in vitro and in vivo.

Our team, rich in academic and industrial experience, has successfully launched a new series of proprietary transfection vector products, NeoLNP™. These products, based on the i-Core LNP, are specifically designed for cell and gene therapies.

We primarily focus on infectious diseases and rare diseases in our product development pipelines. We are committed to developing differentiated products that offer significant clinical benefits.